[
    [
        {
            "time": "",
            "original_text": "恒瑞PD-1获批，百济神州新适应症受理！百亿研发费用下，新一轮市场争夺战要这样打？",
            "features": {
                "keywords": [
                    "恒瑞",
                    "PD-1",
                    "百济神州",
                    "新适应症",
                    "研发费用",
                    "市场争夺"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞PD-1获批，百济神州新适应症受理！百亿研发费用下，新一轮市场争夺战要这样打？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【国金行业纵横】中国医药研发蓬勃兴起：转型、创新、发展 | 第22期",
            "features": {
                "keywords": [
                    "医药研发",
                    "蓬勃兴起",
                    "转型",
                    "创新",
                    "发展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【国金行业纵横】中国医药研发蓬勃兴起：转型、创新、发展 | 第22期",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-31",
            "original_text": "公告点题｜5月31日这些公告有看头",
            "features": {
                "keywords": [
                    "公告",
                    "5月31日"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "公告点题｜5月31日这些公告有看头",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]